Trial | No. of pts | Regimens (per arm) | No. of pts (Male) | CIK Regimens | Culture of CIK cell |
---|---|---|---|---|---|
Dong 2009 [24] | 127 | CIK (3 course) | 41 (31) | 1.0-2.0 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | CIK (6 course) | 43 (32) |  |  |
 |  | Surgery only | 43 (34) |  |  |
Weng 2008 [20] | 85 | TACE + RFA + CIK | 45 (31) | 1.0-1.5 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + RFA | 40 (29) |  |  |
Zhao 2006 [21] | 64 | TACE + RFA | 31 (29) | 1.1-1.5 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + RFA + CIK | 33 (30) |  |  |
Pan 2010 [22] | 83 | TACE + RFA + CIK | 42 (37) | > 1.0 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + RFA | 41 (34) |  |  |
Hao 2010 [19] | 146 | TACE | 74 (64) | 1.0-5.0 × 1010 per course | SFM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + CIK | 72 (65) |  |  |
Lu 2008 [25] | 30 | CIK | 12 (UK) | 1.6 × 1010 per course | SFM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | Surgery alone | 18 (UK) |  |  |
Zhang 2007 [16] | 44 | TACE | 20 (UK) | 8.0 × 109 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + CIK | 24(UK) |  |  |
Guo 2007 [17] | 61 | TACE | 31 (UK) | 1.0-1.2 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + CIK | 30 (UK) |  |  |
Zhang 2006 [27] | 144 | TACE | 30 (UK) | 1.0-1.2 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a IL-2 |
 |  | TACE + CIK | 16 (UK) |  |  |
 |  | TACE + PEI | 62 (UK) |  |  |
 |  | TACE + PEI + CIK | 36 (UK) |  |  |
Shi 2007 [28] | 252 | TACE | 134 (UK) | 1.0-1.2 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + PEI | 80 (UK) |  |  |
 |  | TACE + CIK | 38 (UK) |  |  |
Hao 2006 [18] | 67 | TACE + CIK | 21 (17) | 1.0-5.0 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE | 46 (45) |  |  |
Wan 2008 [23] | 61 | TACE + RFA | 34 (23) | 1.0 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | TACE + RFA + CIK | 27 (18) |  |  |
Yu 2009 [26] | 50 | TACE + CIK | 25 (22) | 1.0-1.2 × 1010 per course | CM, IFN-γ, CD3McAb, IL-1a, IL-2 |
 |  | Surgery alone | 25 (23) |  |  |